This Integrated Preclinical\/Clinical Program for HIV Topical Microbicides (IPCP-HTM) brings together a network of investigators representing two companies and five academic institutions to perform multidisciplinary preclinical and exploratory clinical studies with the goal of advancing a safe, novel trivalent topical microbicide, mapp66.\u00a0 This microbicide formulation is comprised of three monoclonal antibodies (mAbs), produced by genetic engineering in Nicotiana benthamiana (-N), that are designed to block distinct mechanisms of HIV sexual transmission.\u00a0 Success of this IPCP-HTM will rely upon an Administrative Core (Core A) that will provide scientific and administrative leadership in coordinating the six Scientific Projects, and the multiple sites that make up this IPCP-HTM program.\u00a0 The Administrative Core will also coordinate data and materials acquisition and sharing so that the research progresses in an integrated iterative fashion to meet individual project and programmatic milestones.<\/p>\n
The Specific Aims of the Administrative Core are:<\/p>\n
1.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To provide scientific leadership and administrative oversight.\u00a0 Specifically, Core A will establish an Executive Committee (EC) for ongoing assessment of project and core milestones, resource allocation and changes to the experimental design.\u00a0 Core A will also convene a Scientific Advisory Panel (SAP) to review the program in years 3 and 5.\u00a0 Core A will facilitate communication through scheduled conference calls and investigator meetings, provide financial and administrative support, and insure adherence to institutional and federal guidelines<\/p>\n
2.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 To coordinate data and materials acquisition and sharing to insure that project and program milestones are met.\u00a0 Specifically, Core A will be responsible for the reagent\/research material and data management and sharing plan, for monitoring milestone achievements and coordinating biostatistical services, if required by the individual projects\/cores.<\/p>\n","protected":false},"excerpt":{"rendered":"
This Integrated Preclinical\/Clinical Program for HIV Topical Microbicides (IPCP-HTM) brings together a network of investigators representing two companies and five academic institutions to perform multidisciplinary preclinical and exploratory clinical studies with the goal of advancing a safe, novel trivalent topical microbicide, mapp66.\u00a0 This microbicide formulation is comprised of three monoclonal antibodies (mAbs), produced by genetic […]<\/p>\n","protected":false},"author":2546,"featured_media":0,"parent":0,"menu_order":2,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/pages\/56"}],"collection":[{"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/users\/2546"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/comments?post=56"}],"version-history":[{"count":7,"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/pages\/56\/revisions"}],"predecessor-version":[{"id":364,"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/pages\/56\/revisions\/364"}],"wp:attachment":[{"href":"https:\/\/www.bumc.bu.edu\/ipcp\/wp-json\/wp\/v2\/media?parent=56"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}